Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
4.070
-0.830 (-16.94%)
At close: Mar 20, 2026, 4:00 PM EDT
4.390
+0.320 (7.86%)
After-hours: Mar 20, 2026, 6:03 PM EDT
Aardvark Therapeutics Market Cap
Aardvark Therapeutics has a market cap or net worth of $88.62 million as of March 20, 2026. Its market cap has decreased by -56.47% in one year.
Market Cap
88.62M
Enterprise Value
-37.19M
1-Year Change
-56.47%
Ranking
Category
Stock Price
$4.07
Market Cap Chart
Since the IPO on February 13, 2025, Aardvark Therapeutics's market cap has decreased from $342.15M to $88.62M, a decrease of -74.10%. That is a compound annual growth rate of -70.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 88.62M | -68.99% |
| Dec 31, 2025 | 285.77M | -16.48% |
| Feb 13, 2025 | 342.15M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Seer, Inc. | 94.79M |
| Cognition Therapeutics | 94.45M |
| Verrica Pharmaceuticals | 93.62M |
| Reviva Pharmaceuticals Holdings | 93.48M |
| Fortress Biotech | 92.80M |
| Pyxis Oncology | 91.53M |
| Anixa Biosciences | 88.85M |
| Cingulate | 85.82M |